Heart Disease News and Research

Latest Heart Disease News and Research

UCSF scientists to receive two grants for personalized medicine research

UCSF scientists will receive two grants totaling $15.1 million over the next five years to expand their research into how genes affect an individual's response to medication and to strengthen a global network of researchers involved in these efforts.

7 Sep 2010

Bligh explains plans for asset sales

According to Queensland Premier Anna Bligh, new developments are on the horizon only if her Government continues with the sell off of $15 billion of public assets. She revealed this in her annual State of the State address at the mid point of her term in Government yesterday while reviewing the past 18 months and forecasting the next stage of the state's development.

7 Sep 2010

Short sleep duration associated with elevated risk of diabetes, heart disease and stroke

People who sleep less than six hours a night may be three times more likely to develop a condition which leads to diabetes and heart disease, according to researchers at the University of Warwick.

7 Sep 2010

Medtronic launches CoreValve delivery system with AccuTrak Stability Layer for TAVI

Medtronic, Inc. today announced CE Mark approval and the first global use and launch of the Medtronic CoreValve® delivery system with AccuTrak™ Stability Layer for transcatheter aortic valve implantation (TAVI). AccuTrak's proprietary technology allows physicians to achieve enhanced control and accuracy in the deployment of the CoreValve device.

7 Sep 2010

AtheroMed initiates enrollment in Phoenix Atherectomy catheter trial for PAD

AtheroMed, Inc. announced today the start of enrollment in the EASE study to evaluate the safety and effectiveness of the Phoenix Atherectomy™ catheter, a minimally invasive device for the treatment of peripheral arterial disease (PAD) in the legs. EASE - Endovascular Atherectomy Safety and Effectiveness - is an FDA-approved Investigational Device Exemption (IDE) clinical trial that will enroll 90 patients at up to 20 clinical sites.

7 Sep 2010

St. Jude Medical to invest $60M in CardioMEMS

St. Jude Medical, Inc., a global medical device company, and privately-held CardioMEMS today announced that they have reached an agreement under which St. Jude Medical will make a $60 million equity investment in CardioMEMS, a medical device company that has developed a wireless sensing and communication technology to assess cardiac performance.

7 Sep 2010

GI Dynamics announces data on EndoBarrier therapy for type 2 diabetes, obesity

GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced data with the EndoBarrier Gastrointestinal Liner at 12 months showing significant weight loss and cardiovascular and metabolic improvements in obese patients.

7 Sep 2010

NextGen executes agreement with MKMG to deploy EHR solution

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and leading provider of healthcare information systems and connectivity solutions, today announced it has executed an agreement with Mount Kisco Medical Group, PC (MKMG) to deploy NextGen Ambulatory EHR (Electronic Health Record), NextGen Practice Management, and the NextGen Patient portal.

7 Sep 2010

Medtronic announces international launch of Resolute Integrity Stent System

Medtronic, Inc. (NYSE: MDT), announces the CE (Conformite Europeene) mark and international launch of the Resolute Integrity Stent System for the treatment of coronary artery disease, a leading cause of death and poor quality of life.

7 Sep 2010

Hallucinogen psilocybin safe for administration in patients with advanced-stage cancer and anxiety: Study

A pilot study suggests the hallucinogen psilocybin may be feasible and safe to administer to patients with advanced-stage cancer and anxiety, with promising effects on mood, according to a report published online today that will appear in the January 2011 print issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

7 Sep 2010

Physical qualities can influence stem cell differentiation mechanism: Research

A researcher at the Hebrew University of Jerusalem, together with Israeli and foreign collaborators, has revealed how physical qualities and not only chemical ones may have an influence in determining how adult stem cells from the bone marrow develop into differentiated ones. This represents an important step in understanding the mechanisms that direct and regulate the specialization of stem cells from their undefined state.

7 Sep 2010

An overview on low-carbohydrate diets

Headlines make news, but don't read too much into current headlines about a recent study titled "Low-Carbohydrate Diets and All-Cause and Cause-Specific Mortality," published in the September 7, 2010, issue of Annals of Internal Medicine. Although the headlines may say the study suggests that long-term adherence to a low-carb diet based heavily on animal protein may reduce lifespan, Dr. Funga, who was the lead author of the study, says that her research "is not representative of popular low-carb eating plans

7 Sep 2010

Researchers to develop new treatment strategy for cancer

Cancer is a difficult disease to treat because it's a personal disease. Each case is unique and based on a combination of environmental and genetic factors. Conventional chemotherapy employs treatment with one or more drugs, assuming that these medicines are able to both "diagnose" and "treat" the affected cells. Many of the side effects experienced by chemotherapy patients are due to the fact that the drugs they are taking aren't selective enough.

7 Sep 2010

RWJF unites civil rights organizations to reverse childhood obesity

A $2 million initiative of the Robert Wood Johnson Foundation (RWJF) is bringing together five civil rights organizations with the prominence and strength to help reverse childhood obesity, especially in African-American and Latino communities where the epidemic continues to hit hardest.

7 Sep 2010

Inflammation associated with lower intelligence, premature death: Research

Inflammation is associated with lower intelligence and premature death, according to Swedish scientists from the Karolinska Institute in Stockholm, Sweden. "Those with low-grade inflammation performed more poorly on standardised intelligence tests, even after excluding those with signs of current illness. Inflammation also predicted an increased risk of premature death," said lead researcher Dr Hakan Karlsson.

7 Sep 2010

Chemicals in non-stick cookware elevates cholesterol level among children: Report

Children and teens with higher blood levels of chemicals used in the production of non-stick cookware and waterproof fabrics appear more likely to have elevated total and LDL cholesterol levels, according to a report in the September issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

7 Sep 2010

Microplasmin MIVI-TRUST Phase III program's positive pooled results presented at EURETINA

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, cardiovascular disease and cancer, announces that the pooled results from the successful microplasmin MIVI-TRUST Phase III program were presented today at the EURETINA (European Society of Retina Specialists) Congress in Paris, France.

6 Sep 2010

Plaque-causing bacteria increases risk of heart attack

Plaque-causing bacteria can jailbreak from the mouth into the bloodstream and increase your risk of heart attack says a scientist at the Society for General Microbiology's autumn meeting in Nottingham.

6 Sep 2010

New VA regulation helps to get recognition, treatment for three disorders in Agent Orange exposure

A new VA regulation adding three health conditions to the list of those presumed to have been caused by exposure to the toxic defoliant Agent Orange during the Vietnam War was published this week. Pending a 60-day congressional review, the regulation will make some 200,000 veterans eligible for VA benefits over the next year and a half.

4 Sep 2010

IAS urges to review guidelines for implementing HIV prevention and care

Following the imprisonment of Maxim Popov in April 2010, sentenced to 7 years jail primarily for the promotion of HIV prevention efforts in Uzbekistan, the International AIDS Society (IAS) notes with alarm the detention of a medial practitioner working in HIV prevention in Ukraine.

4 Sep 2010